Pages that link to "Q45304491"
Jump to navigation
Jump to search
The following pages link to Cerebral metabolism and atrophy in huntington's disease determined by18FDG and computed tomographic scan (Q45304491):
Displaying 50 items.
- Brain imaging and cognitive dysfunctions in Huntington's disease (Q24535934) (← links)
- Role of cerebral cortex in the neuropathology of Huntington's disease (Q26829211) (← links)
- Benzodiazepine receptor quantification in Huntington's disease with [(123)I]omazenil and SPECT (Q28363142) (← links)
- Shaping the role of mitochondria in the pathogenesis of Huntington's disease (Q28384036) (← links)
- Unbiased gene expression analysis implicates the huntingtin polyglutamine tract in extra-mitochondrial energy metabolism (Q28469280) (← links)
- Emission tomography contribution to clinical neurology (Q30577801) (← links)
- Positron emission tomography in pediatric neurology (Q30579255) (← links)
- An overview of psychiatric symptoms in Huntington's disease (Q30660685) (← links)
- Imaging in cell-based therapy for neurodegenerative diseases. (Q31015455) (← links)
- Neural bases of dysphoria in early Huntington's disease (Q31139428) (← links)
- The scintigraphic evaluation of Huntington's disease and other movement disorders using single photon emission computed tomography perfusion brain scans (Q31145606) (← links)
- Advances in the understanding of early Huntington's disease using the functional imaging techniques of PET and SPET. (Q31945974) (← links)
- Neuroimaging and neuropsychology of the striatum. Bridging basic science and clinical practice (Q32136157) (← links)
- Functional imaging in Huntington's disease (Q33403110) (← links)
- Brain imaging in dementia of the Alzheimer type (Q33432903) (← links)
- Protection from mitochondrial complex II inhibition in vitro and in vivo by Nrf2-mediated transcription (Q33551416) (← links)
- EMG responses in leg muscles to postural perturbations in Huntington's disease (Q33588640) (← links)
- Reduced regional cerebral blood flow in Huntington's disease studied by SPECT. (Q33592003) (← links)
- Positron emission tomography in cases of chorea with different underlying diseases (Q33629536) (← links)
- Prefrontal cortical blood flow and cognitive function in Huntington's disease (Q33630293) (← links)
- Imaging of cerebral blood flow markers in Huntington's disease using single photon emission computed tomography (Q33630745) (← links)
- PET and movement disorders (Q33631701) (← links)
- Copy-number variation of the neuronal glucose transporter gene SLC2A3 and age of onset in Huntington's disease (Q33649261) (← links)
- QEEG Measures in Huntington’s Disease: A Pilot Study (Q33734662) (← links)
- Pathophysiology of secondary depressions in the elderly (Q33792252) (← links)
- Functional neuroimaging and chorea: a systematic review (Q33820298) (← links)
- Brain imaging techniques in the diagnosis of dementia (Q33883142) (← links)
- D-β-Hydroxybutyrate Is Protective in Mouse Models of Huntington's Disease (Q34023773) (← links)
- Insulin receptors and insulin action in the brain: review and clinical implications (Q34105422) (← links)
- Non-invasive in vivo imaging of transplant function. (Q34120750) (← links)
- Striatal tissue transplantation in non-human primates (Q34120774) (← links)
- Therapeutic approaches to preventing cell death in Huntington disease (Q34411338) (← links)
- Olfactory recognition: differential impairments in early and late Huntington's and Alzheimer's diseases (Q34563171) (← links)
- Abnormal mitochondrial dynamics, mitochondrial loss and mutant huntingtin oligomers in Huntington's disease: implications for selective neuronal damage (Q34627072) (← links)
- Positron emission tomography in patients with clinically diagnosed Alzheimer's disease (Q34727718) (← links)
- Glucose transporter 3 is a rab11-dependent trafficking cargo and its transport to the cell surface is reduced in neurons of CAG140 Huntington's disease mice (Q34979045) (← links)
- Early deficits in glycolysis are specific to striatal neurons from a rat model of huntington disease (Q35058593) (← links)
- Relationship of depression to diabetes types 1 and 2: epidemiology, biology, and treatment (Q35189666) (← links)
- New insights into the clinical features, pathogenesis and molecular genetics of Huntington disease (Q35243890) (← links)
- Differential effects of the Huntington's disease CAG mutation in striatum and cerebellum are quantitative not qualitative (Q35288349) (← links)
- Evidence of thalamic disinhibition in patients with hemichorea: semiquantitative analysis using SPECT. (Q35466072) (← links)
- The use of positron emission tomography in the clinical assessment of dementia (Q35532399) (← links)
- Abnormalities in the tricarboxylic Acid cycle in Huntington disease and in a Huntington disease mouse model (Q35619586) (← links)
- Regional vulnerability in Huntington's disease: fMRI-guided molecular analysis in patients and a mouse model of disease (Q35619936) (← links)
- Mutant huntingtin, abnormal mitochondrial dynamics, defective axonal transport of mitochondria, and selective synaptic degeneration in Huntington's disease (Q35645271) (← links)
- The role of positron emission tomography imaging in movement disorders (Q35692956) (← links)
- The differential role of premotor frontal cortex and basal ganglia in motor sequence learning: evidence from focal basal ganglia lesions (Q35807189) (← links)
- pH as a biomarker of neurodegeneration in Huntington's disease: a translational rodent-human MRS study. (Q35939218) (← links)
- Using advances in neuroimaging to detect, understand, and monitor disease progression in Huntington's disease (Q36045301) (← links)
- Positron emission tomography imaging of transplant function. (Q36045402) (← links)